aasld/easl hcv special conference session 2: viral resistance perspectives for clinicians
Published 10 years ago • 646 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
4:59
aasld/easl hcv special conference session 1: birth cohort screening for hcv
-
19:40
debrief of easl special conference on new perspectives in hcv infection
-
5:58
aasld/easl special conference session 3: therapeutic options
-
3:58
aasld: hepatitis c update session coverage
-
18:27
consensus aasld-easl hbv treatment endpoint and hbv cure definition | anna s. lok, md, dsc
-
4:23
advances for practitioners: new treatments for hepatitis c
-
38:36
easl recommendations on treatment of hepatitis c 2016
-
28:48
expert panel discussion, easl recommendations on the treatment of hcv, 2014
-
5:50
understanding hepatitis c
-
5:14
interview with 2015 aasld president at the liver meeting® 2014
-
25:40
easl recommendations on treatment of hepatitis c, 2014
-
24:11
new developments in hepatitis c care and treatment
-
3:33
aasld 2015 liver meeting – why every trainee should attend
-
24:10
easl hcc summit 2017 - basic science debrief
-
1:50
aasld/ilts transplant course-bench & bedside @ the liver meeting ® 2015
-
24:31
treatment of hepatitis c | sammy saab, md, mph | ucla digestive disease
-
6:27
cost and resistance among factors to consider in hepatitis c treatment
-
1:00:41
take action against viral hcv by leveraging screening programs and hcv ag